NCT07754734: STUPP Regimen With or Without Lenvatinib for Newly Diagnosed Glioblastoma With MGMT Promoter Methylation
- State
- Not started
- Phase
- Phase 2
- People
- 138 planned
- Started
- 10 Aug 2026
- Primary completion
- 31 Jul 2029
- Arms
- experimental group:Lenvatinib + TMZ + radiotherapy
- Results
- None posted
- 10 Aug 2026: Trial registered